Status:
COMPLETED
Role of CGMS Usage in Predicting Risk for Hypoglycemia
Lead Sponsor:
University of Minnesota
Conditions:
Type 2 Diabetes Mellitus
Hypoglycemia
Eligibility:
All Genders
18+ years
Brief Summary
This is a clinical study to examine rates hypoglycemia (self-report, EHR review, and review of values from a FDA approved continuous glucose monitoring system (CGMS)). Subjects will wear either blinde...
Eligibility Criteria
Inclusion
- Type 2 Diabetes
- 18 years or older
Exclusion
- Type 1 diabetes
- Current pregnancy or anticipation of pregnancy during study period
- At screening visit, HR\> 130 or SBP\>160 or DBP\>100 which remains present on recheck
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03481530
Start Date
October 1 2018
End Date
September 30 2025
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455